SFRP2 Potentiates Colon Cancer Metastasis by Stabilizing Snai1 Protein via USP11
Background
Metastatic colon cancer presents a significant clinical challenge with poor patient prognosis, as current therapies often fall short in effectively managing advanced disease. Recent research highlights secreted frizzled-related protein 2 (SFRP2) as overexpressed in metastatic cases, suggesting its role in progression. However, the precise molecular mechanisms by which SFRP2 drives colon cancer metastasis, particularly its interaction with key oncogenic pathways like epithelial-mesenchymal transition (EMT), remained largely undefined. Understanding this gap could unlock novel therapeutic targets.
Study Design
Researchers investigated SFRP2's role in colon cancer progression using both in vitro assays and in vivo experiments. In vitro studies assessed the impact of SFRP2 on colon cancer cell migration and invasion, alongside cell proliferation, using standard colon cancer cell culture models. Mechanistic investigations focused on identifying SFRP2's interacting partners and its influence on protein stability and ubiquitination. In vivo experiments were conducted to further validate the role of the SFRP2-Snai1 interaction in enhancing metastatic potential in a relevant animal model, though specific animal species or n were not detailed.
